|
Volume 271,
Number 11,
Issue of March 15, 1996 pp. 6233-6240
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Mutagenic
Analysis of Platelet Thromboxane Receptor Cysteines
ROLES IN LIGAND BINDING AND RECEPTOR-EFFECTOR COUPLING
(Received for publication, September 7,
1995; and in revised form, December 22, 1995)
Drew D.
D'Angelo,
Jeremy
J.
Eubank,
Michael G.
Davis,
Gerald
W.
Dorn
II
The human platelet thromboxane A receptor is a
member of the G-protein-coupled superfamily of receptors. Previous
pharmacologic studies examining the effects of biochemical reduction,
oxidation, or sulfhydryl alkylation on thromboxane receptors have
suggested a role for cysteines in determining receptor binding
characteristics. To characterize the roles of individual cysteines, we
employed site-directed mutagenesis to substitute serines for cysteines
at seven positions throughout the human K562 thromboxane receptor and
analyzed mutant receptor radioligand
([1S-(1 ,2 (5Z),3 (1E,3S),4 ]-7-[3-(3-hydroxy-4-(p-iodophenoxy)-1-butenyl)-7-oxabicyclo-[2.2.1]heptane-2-yl]-5-heptenoic
acid) binding and calcium signaling. Replacing cysteines in the amino
terminus (amino acid position 11), and transmembrane domains two and
six (positions 68 and 257) had little effect on thromboxane receptor
binding or signaling. Introduction of serines for cysteines in the
first (position 105) or the second (position 183) extracellular loop
eliminated thromboxane receptor binding, consistent with the existence
of a critical disulfide bond between these positions. Mutation of a
second cysteine in extracellular loop one (position 102) resulted in a
receptor with decreased binding affinity and low binding capacity that
transduced only a low amplitude calcium signal, suggesting the
involvement of a free sulfhydryl group at this location in
receptor-ligand interactions. Finally, mutation of the cysteine at
position 223, located in intracellular loop three, resulted in a
receptor with normal ligand binding characteristics, but which did not
transduce a calcium signal. Some additional amino acid substitutions in
this region of the receptor (Cys-223 Ala, Thr-221 Met)
resulted in receptors that had normal binding but transduced low
amplitude calcium signals, while other mutations in the same region
(His-224 Arg and His-227 Arg) exhibited normal binding
and calcium signaling characteristics. These findings demonstrate that
cysteines in extracellular loops one and two contribute to proper
ligand binding to thromboxane receptors and show the importance of
discrete amino acid sequences in the third intracellular loop,
especially cysteine 223, in thromboxane receptor-effector coupling.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Stitham, S. R. Gleim, K. Douville, E. Arehart, and J. Hwa
Versatility and Differential Roles of Cysteine Residues in Human Prostacyclin Receptor Structure and Function
J. Biol. Chem.,
December 1, 2006;
281(48):
37227 - 37236.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. T. Khasawneh, J.-S. Huang, J. W. Turek, and G. C. L. Breton
Differential Mapping of the Amino Acids Mediating Agonist and Antagonist Coordination with the Human Thromboxane A2 Receptor Protein
J. Biol. Chem.,
September 15, 2006;
281(37):
26951 - 26965.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Capra, A. Veltri, C. Foglia, L. Crimaldi, A. Habib, M. Parenti, and G. E. Rovati
Mutational Analysis of the Highly Conserved ERY Motif of the Thromboxane A2 Receptor: Alternative Role in G Protein-Coupled Receptor Signaling
Mol. Pharmacol.,
October 1, 2004;
66(4):
880 - 889.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Ding, S. Kim, R. T. Dorsam, J. Jin, and S. P. Kunapuli
Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270
Blood,
May 15, 2003;
101(10):
3908 - 3914.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-P. So, J. Wu, G. Huang, A. Huang, D. Li, and K.-H. Ruan
Identification of Residues Important for Ligand Binding of Thromboxane A2 Receptor in the Second Extracellular Loop Using the NMR Experiment-guided Mutagenesis Approach
J. Biol. Chem.,
March 21, 2003;
278(13):
10922 - 10927.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Turek, T. Halmos, N. L. Sullivan, K. Antonakis, and G. C. Le Breton
Mapping of a Ligand-binding Site for the Human Thromboxane A2 Receptor Protein
J. Biol. Chem.,
May 3, 2002;
277(19):
16791 - 16797.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Wright, D. Abran, M. Bhattacharya, X. Hou, S. G. Bernier, A. Bouayad, J.-C. Fouron, A. Vazquez-Tello, M. H. Beauchamp, R. I. Clyman, et al.
Prostanoid receptors: ontogeny and implications in vascular physiology
Am J Physiol Regulatory Integrative Comp Physiol,
November 1, 2001;
281(5):
R1343 - R1360.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-O. Chung, Q. Yang, K. J. Catt, and K. K. Arora
Expression and Function of the Gonadotropin-releasing Hormone Receptor Are Dependent on a Conserved Apolar Amino Acid in the Third Intracellular Loop
J. Biol. Chem.,
December 10, 1999;
274(50):
35756 - 35762.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Narumiya, Y. Sugimoto, and F. Ushikubi
Prostanoid Receptors: Structures, Properties, and Functions
Physiol Rev,
October 1, 1999;
79(4):
1193 - 1226.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Stillman, M. D. Breyer, and R. M. Breyer
Importance of the Extracellular Domain for Prostaglandin EP2 Receptor Function
Mol. Pharmacol.,
September 1, 1999;
56(3):
545 - 551.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Pawate, K. L. Schey, G. P. Meier, M. E. Ullian, D. E. Mais, and P. V. Halushka
Expression, Characterization, and Purification of C-terminally Hexahistidine-tagged Thromboxane A2 Receptors
J. Biol. Chem.,
August 28, 1998;
273(35):
22753 - 22760.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Walsh, J. F. Foley, and B. T. Kinsella
Characterization of the Role of N-Linked Glycosylation on the Cell Signaling and Expression of the Human Thromboxane A2 Receptor Alpha and Beta Isoforms
J. Pharmacol. Exp. Ther.,
August 1, 1998;
286(2):
1026 - 1036.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. F. Spurney and T. M. Coffman
The C-Terminus of the Thromboxane Receptor Contributes to Coupling and Desensitization in a Mouse Mesangial Cell Line
J. Pharmacol. Exp. Ther.,
October 1, 1997;
283(1):
207 - 215.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
F. S. Monteclaro and I. F. Charo
The Amino-terminal Domain of CCR2 Is Both Necessary and Sufficient for High Affinity Binding of Monocyte Chemoattractant Protein 1. RECEPTOR ACTIVATION BY A PSEUDO-TETHERED LIGAND
J. Biol. Chem.,
September 12, 1997;
272(37):
23186 - 23190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Audoly and R. M. Breyer
The Second Extracellular Loop of the Prostaglandin EP3 Receptor Is an Essential Determinant of Ligand Selectivity
J. Biol. Chem.,
May 23, 1997;
272(21):
13475 - 13478.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. W. Dorn II, M. G. Davis, and D. D. D'Angelo
Structural Determinants for Agonist Binding Affinity to Thromboxane/Prostaglandin Endoperoxide (TP) Receptors. ANALYSIS OF CHIMERIC RAT/HUMAN TP RECEPTORS
J. Biol. Chem.,
May 9, 1997;
272(19):
12399 - 12405.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|